Page 3 - Revive Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Revive therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Revive Therapeutics Today - Breaking & Trending Today

Revive Therapeutics' experimental COVID treatment fails in late-stage study

The company was evaluating the safety and efficacy of its oral treatment, bucillamine, in the study which enrolled 713 patients with mild to moderate COVID-19. Earlier in May, Revive Therapeutics said it was halting the study as it was likely that it would not meet the main goal based on the recommendation of an independent data safety monitoring board. The company said on Thursday it was pursuing certain initiatives including partnerships and government support to continue the development of bucillamine. ....

Sriparna Roy , Shounak Dasgupta , Revive Therapeutics ,

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Regulation Services Provider , Psilocin Pharma Corp , Company Us Food Drug Administration , Michael Frankchief Executive Officerrevive Therapeutics Ltd Tel , Therapeutics Ltd , Neither The Canadian Securities Exchange , Wall Street , Drug Administration , Data Safety Monitoring Board , Orphan Drug , Fast Track , Breakthrough Therapy , Rare Pediatric Disease , Canadian Securities Exchange , Revive Therapeutics ,